Abstract:To determine if contrast-enhanced CT imaging performed in patients during their episode of AKI contributes to major adverse kidney events (MAKE). A propensity score–matched analysis of 1127 patients with AKI defined by KDIGO criteria was done. Their mean age was 63 ± 16 years with 56% males. A total of 419 cases exposed to CT contrast peri-AKI were matched with 798 non-exposed controls for 14 covariates including comorbidities, acute illnesses, and initial AKI severity; outcomes including MAKE and renal recovery in hospital were compared using bivariate analysis and logistic regression. MAKE was a composite of mortality, renal replacement therapy, and doubling of serum creatinine on discharge over baseline; renal recovery was classified as early versus late based on a 7-day timeline from AKI onset to nadir creatinine or cessation of renal replacement therapy in survivors. Sixty-two patients received cumulatively > 100 mL of CT contrast, 143 patients had > 50–100 mL, and 214 patients had 50 mL or less; MAKE occurred in 34%, 17%, and 21%, respectively, as compared with 20% in non-exposed controls (p = 0.008 for patients with > 100 mL contrast versus none). More contrast-exposed patients experienced late renal recovery (27% versus 20%) and longer hospital days (median 10 versus 8) than non-exposed patients (all p < 0.01). On multivariate analysis, cumulative CT contrast > 100 mL was independently associated with MAKE (odds ratio 2.39 versus non-contrast, adjusted for all confounders, p = 0.005); cumulative CT contrast under 100 mL was not associated with MAKE. High cumulative volume of CT contrast administered to patients with AKI is associated with worse short-term renal outcomes and delayed renal recovery. • Cumulative intravenous iodinated contrast for CT imaging of more than 100 mL, during an episode of acute kidney injury, was independently associated with worse renal outcomes and less renal recovery. • These adverse outcomes including renal replacement therapy were not more frequent in similar patients who received cumulatively 100 mL or less of CT contrast, compared with non-exposed patients. • More patients with CT contrast exposure during acute kidney injury experienced delayed renal recovery.

Repeat Intravenous Administration within 2 Weeks of Iodinated Contrast Media: Effect on the Renal Function

Contrast-induced Nephropathy in 532 Patients Undergoing Coronary Intervention

Risk factors and recent advances in the prevention of contrast - induced nephropathy

A Prospective Study on the Risk of Contrast Induced Nephropathy in the Patients Who Underwent Contrast-Enhanced CT Examination

Effects of contrast media on renal functions of the patients undergoing coronary angiography

Renal adverse effect of intravenous administration of iodixanol (270mg I/ml)

Is intravenous iodinated contrast medium administration really harmful in hospitalized acute kidney injury patients: a propensity score–matched study

The Controversy of Contrast-Induced Nephropathy With Intravenous Contrast: What Is the Risk?

Renal Tolerability of Iopromide and Iodixanol in 562 Renally Impaired Patients Undergoing Cardiac Catheterisation: the Direct Study

Contrast-Induced Nephropathy: A Review of Mechanisms and Risks

Update on the renal toxicity of iodinated contrast drugs used in clinical medicine

Outpatient Renal Function Screening Before Contrast-Enhanced CT Examinations

Effect of the low-osmolality nonionic contrast media on renal function in patients undergoing coronary intervention: a prospective study

Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation

Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants

Epidemiology of contrast-induced nephropathy after computerized tomography

Patients with Different Stages of Chronic Kidney Disease Undergoing Intravenous Contrast-Enhanced Computed Tomography—The Incidence of Contrast-Associated Acute Kidney Injury

Cumulative Iodinated Contrast Exposure for Computed Tomography During Acute Kidney Injury and Major Adverse Kidney Events

Acute Kidney Injury in Patients with Nephrotic Syndrome Undergoing Contrast-Enhanced CT for Suspected Venous Thromboembolism: a Propensity Score-Matched Retrospective Cohort Study

Post-Hoc Study: Intravenous Hydration Treatment in Chinese Patients with High Risk of Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention

Incidence of contrast-associated acute kidney injury: a prospective cohort